These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 24091000)

  • 21. Ceftazidime-avibactam and comparator agents tested against urinary tract isolates from a global surveillance program (2011).
    Flamm RK; Sader HS; Farrell DJ; Jones RN
    Diagn Microbiol Infect Dis; 2014 Nov; 80(3):233-8. PubMed ID: 25128477
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Susceptibility trends and molecular characterization of Gram-negative bacilli associated with urinary tract and intra-abdominal infections in Jordan and Lebanon: SMART 2011-2013.
    Hayajneh WA; Hajj A; Hulliel F; Sarkis DK; Irani-Hakimeh N; Kazan L; Badal RE
    Int J Infect Dis; 2015 Jun; 35():56-61. PubMed ID: 25917963
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antimicrobial resistance among Gram-negative bacilli causing infections in intensive care unit patients in the United States between 1993 and 2004.
    Lockhart SR; Abramson MA; Beekmann SE; Gallagher G; Riedel S; Diekema DJ; Quinn JP; Doern GV
    J Clin Microbiol; 2007 Oct; 45(10):3352-9. PubMed ID: 17715376
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro susceptibility pattern of cephalosporin-resistant Gram-negative bacteria.
    Punpanich W; Tantichattanon W; Wongwatcharapaiboon S; Treeratweeraphong V
    J Med Assoc Thai; 2008 Oct; 91 Suppl 3():S21-7. PubMed ID: 19255989
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antimicrobial resistance of Gram-negative bacilli isolates from inpatients and outpatients at Yaounde Central Hospital, Cameroon.
    Piéboji JG; Koulla-Shiro S; Ngassam P; Adiogo D; Njine T; Ndumbe P
    Int J Infect Dis; 2004 May; 8(3):147-54. PubMed ID: 15109589
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro susceptibilities of aerobic and facultative anaerobic Gram-negative bacilli isolated from patients with intra-abdominal infections at a medical center in Taiwan: results of the Study for Monitoring Antimicrobial Resistance Trends (SMART) 2002-2006.
    Chen WY; Jang TN; Huang CH; Hsueh PR
    J Microbiol Immunol Infect; 2009 Aug; 42(4):317-23. PubMed ID: 19949755
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Susceptibility of gram-negative aerobic bacilli from intra-abdominal pathogens to antimicrobial agents collected in the United States during 2011.
    Hawser SP; Badal RE; Bouchillon SK; Hoban DJ; Hackel MA; Biedenbach DJ; Goff DA
    J Infect; 2014 Jan; 68(1):71-6. PubMed ID: 24016768
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ceftazidime/avibactam activity tested against Gram-negative bacteria isolated from bloodstream, pneumonia, intra-abdominal and urinary tract infections in US medical centres (2012).
    Flamm RK; Farrell DJ; Sader HS; Jones RN
    J Antimicrob Chemother; 2014 Jun; 69(6):1589-98. PubMed ID: 24562613
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Continuous surveillance of antimicrobial resistance among nosocomial gram-negative bacilli from intensive care units in China].
    Chen MJ; Wang H;
    Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):375-81. PubMed ID: 12820912
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antimicrobial resistance among urinary tract infection (UTI) isolates in Europe: results from the SENTRY Antimicrobial Surveillance Program 1997.
    Fluit AC; Jones ME; Schmitz FJ; Acar J; Gupta R; Verhoef J
    Antonie Van Leeuwenhoek; 2000 Feb; 77(2):147-52. PubMed ID: 10768473
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Occurrence of ESBL & Amp-C beta-lactamases & susceptibility to newer antimicrobial agents in complicated UTI.
    Taneja N; Rao P; Arora J; Dogra A
    Indian J Med Res; 2008 Jan; 127(1):85-8. PubMed ID: 18316858
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Survey of bloodstream infections due to gram-negative bacilli: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, and Latin America for the SENTRY Antimicrobial Surveillance Program, 1997.
    Diekema DJ; Pfaller MA; Jones RN; Doern GV; Winokur PL; Gales AC; Sader HS; Kugler K; Beach M
    Clin Infect Dis; 1999 Sep; 29(3):595-607. PubMed ID: 10530454
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antimicrobial susceptibility and extended-spectrum beta-lactamase rates in aerobic gram-negative bacteria causing intra-abdominal infections in Vietnam: report from the Study for Monitoring Antimicrobial Resistance Trends (SMART 2009-2011).
    Biedenbach DJ; Bouchillon SK; Hoban DJ; Hackel M; Phuong DM; Nga TT; Phuong NT; Phuong TT; Badal RE
    Diagn Microbiol Infect Dis; 2014 Aug; 79(4):463-7. PubMed ID: 24923210
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antimicrobial susceptibility among gram-negative isolates collected from intensive care units in North America, Europe, the Asia-Pacific Rim, Latin America, the Middle East, and Africa between 2004 and 2009 as part of the Tigecycline Evaluation and Surveillance Trial.
    Bertrand X; Dowzicky MJ
    Clin Ther; 2012 Jan; 34(1):124-37. PubMed ID: 22154196
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antimicrobial susceptibility of gram-negative pathogens isolated from patients with complicated intra-abdominal infections in South African hospitals (SMART Study 2004-2009): impact of the new carbapenem breakpoints.
    Brink AJ; Botha RF; Poswa X; Senekal M; Badal RE; Grolman DC; Richards GA; Feldman C; Boffard KD; Veller M; Joubert I; Pretorius J
    Surg Infect (Larchmt); 2012 Feb; 13(1):43-9. PubMed ID: 22220506
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative activities of cefepime and piperacillin/tazobactam tested against a global collection of Escherichia coli and Klebsiella spp. with an ESBL phenotype.
    Sader HS; Hsiung A; Fritsche TR; Jones RN
    Diagn Microbiol Infect Dis; 2007 Mar; 57(3):341-4. PubMed ID: 17141461
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Antibiotic resistance rates of extended spectrum beta-lactamase producing Escherichia coli and Klebsiella spp. strains isolated from urinary tract infections in a private hospital].
    Akyar I
    Mikrobiyol Bul; 2008 Oct; 42(4):713-5. PubMed ID: 19149097
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparisons of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
    Jones RN; Sader HS; Fritsche TR; Pottumarthy S
    Diagn Microbiol Infect Dis; 2007 Jan; 57(1):109-16. PubMed ID: 16930923
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surveillance for antimicrobial resistance among clinical isolates of gram-negative bacteria from intensive care unit patients in China, 1996 to 2002.
    Wang H; Chen M;
    Diagn Microbiol Infect Dis; 2005 Mar; 51(3):201-8. PubMed ID: 15766607
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Comparative studies of antimicrobial agents against causative organisms isolated from urinary tract infections (1983). III. Secular changes in susceptibility].
    Kosakai N; Igari J; Kumamoto Y; Sakai S; Shigeta S; Shiraiwa Y; Abe K; Tazaki H; Iri H; Uchida H
    Jpn J Antibiot; 1985 Aug; 38(8):2243-312. PubMed ID: 3935824
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.